Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma

Area of Science:

• Urology
• Oncology
• Nephrology

Background:

• Localized renal cell carcinoma (RCC) requires effective risk stratification for post-surgical surveillance.
• The American Urological Association (AUA) introduced a new risk stratification system based on tumor stage and grade.

Purpose of the Study:

• To evaluate the predictive accuracy of the AUA risk stratification system for progression-free survival (PFS) and cancer-specific survival (CSS).
• To compare the performance of the AUA system against established institutional risk models.

Main Methods:

• Retrospective analysis of the Nephrectomy Registry (1980-2012).
• Inclusion of adult patients with unilateral, M0, clear cell RCC, or papillary RCC.
• Kaplan-Meier method for PFS and CSS estimation.
• Cox proportional hazards regression models with C indexes to assess predictive ability.

Main Results:

• The AUA system achieved C indexes around 0.80 for PFS and CSS in clear cell and papillary RCC.
• For clear cell RCC, the institutional model showed slightly better prediction than the AUA system (PFS: 0.815 vs 0.780; CSS: 0.857 vs 0.811).
• For papillary RCC, the AUA system showed comparable or slightly better prediction for PFS (0.775 vs 0.751) and similar prediction for CSS (0.830 vs 0.803).

Conclusions:

• The AUA stratification system is a parsimonious tool for categorizing localized clear cell and papillary RCC.
• It provides reliable predictive performance for PFS and CSS following surgical treatment.
• The system aids in guiding surveillance strategies for RCC patients.